Samir Agrawal

Role of Smac in human leukaemic cell apoptosis and proliferation.

BH3-domain mimetic compound BH3I-2' induces rapid damage to the inner mitochondrial membrane prior to the cytochrome c release from mitochondria.

PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma.

Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.

Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR.

Assessing the total costs of blood delivery to hospital oncology and haematology patients.

New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups.

Let cost effectiveness models be open to scrutiny.

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia.

Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL.

Safe and efficacious use of recombinant human erythropoietin in malignancy.

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.

Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience.

Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations.

Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.

A patient with CLL and a dry cough.

Optimizing management of invasive mould diseases.

Differential and tumor-specific expression of CD160 in B-cell malignancies.

Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis.

Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract.

A practical critique of antifungal treatment guidelines for haemato-oncologists.

Whole blood stem cell re-infusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 study.